Literature DB >> 1138871

The conformation of glucagon: predictions and consequences.

P Y Chou, G D Fasman.   

Abstract

It is proposed that glucagon, a polypeptide hormone, is delicately balanced between two major conformational states. Utilizing a new predictive model [Chou, P.Y., and Fasman, G.D. (1974), Biochemistry 13, 222] which considers all the conformational states in proteins (helix, beta sheet, random coil, and beta turns), the secondary structural regions of glucagon are computed herein. The conformational sensitivity of glucagon may be due to residues 19-27 which have both alpha-helical potential (mean value of Palpha = 1.19) as well as beta-sheet potential (mean value of Pbeta = 1.25). Two conformational states are predicted for glucagon. In predicted form (a), residues 5-10 form a beta-sheet region while residues 19-27 form an alpha-helical region (31% alpha, 21% beta) agreeing well with the circular dichroism (CD) spectra of glucagon. The similarity in the CD spectra of glucagon and insulin further suggests the presence of beta structure in glucagon, since X-ray analysis of insulin showed 24% beta sheet. In predicted form (b), both regions, residues 5-10 and residues 19-27, are beta sheets sheets (0% alpha, 52% beta) in agreement with the infrared spectral evidence that glucagon gels and fibrils have a predominant beta-sheet conformation. Since three reverse beta turns are predicted at residues 2-5, 10-13, and 15-18, glucagon may possess tertiary structure in agreement with viscosity and tritium-hydrogen exchange experiments. A proposal is offered concerning an induced alpha yields beta transition at residues 22-27 in glucagon during receptor site binding. Amino acid substitutions are proposed which should disrupt the beta sheets of glucagon with concomitant loss of biological activity. The experimental findings that glucagon aggregates to form dimers, trimers, and hexamers can be explained in terms of beta-sheet interactions as outlined in the present predictive model. Thus the conflicting conclusions of previous workers, concerning the conformation of glucagon in different environments, can be rationalized by the suggested conformational transition occurring within the molecule.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1138871     DOI: 10.1021/bi00682a037

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  17 in total

1.  Predicting conformational switches in proteins.

Authors:  M Young; K Kirshenbaum; K A Dill; S Highsmith
Journal:  Protein Sci       Date:  1999-09       Impact factor: 6.725

2.  Predicting allosteric switches in myosins.

Authors:  K Kirshenbaum; M Young; S Highsmith
Journal:  Protein Sci       Date:  1999-09       Impact factor: 6.725

3.  Pharmacokinetics modeling of exogenous glucagon in type 1 diabetes mellitus patients.

Authors:  Dayu Lv; Marc D Breton; Leon S Farhy
Journal:  Diabetes Technol Ther       Date:  2013-08-26       Impact factor: 6.118

4.  Prediction of the conformation of the histones.

Authors:  G D Fasman; P Y Chou; A J Adler
Journal:  Biophys J       Date:  1976-10       Impact factor: 4.033

5.  The prediction of the conformation of membrane proteins from the sequence of amino acids.

Authors:  N M Green; M T Flanagan
Journal:  Biochem J       Date:  1976-03-01       Impact factor: 3.857

6.  Thermodynamics of the self-association of glucagon.

Authors:  S Formisano; M L Johnson; H Edelhoch
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

7.  Cul3 regulates cyclin E1 protein abundance via a degron located within the N-terminal region of cyclin E.

Authors:  Brittney Davidge; Katia Graziella de Oliveira Rebola; Larry N Agbor; Curt D Sigmund; Jeffrey D Singer
Journal:  J Cell Sci       Date:  2019-11-06       Impact factor: 5.285

8.  Conformational studies of the synthetic precursor-specific region of preproparathyroid hormone.

Authors:  M Rosenblatt; N V Beaudette; G D Fasman
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

Review 9.  Structure-conformation-activity studies of glucagon and semi-synthetic glucagon analogs.

Authors:  V J Hruby
Journal:  Mol Cell Biochem       Date:  1982-04-16       Impact factor: 3.396

10.  N-acetyl oxyntomodulin30-37: pharmacokinetics and activity on gastric acid secretion.

Authors:  C Carles-Bonnet; C Jarrousse; H Niel; J Martinez; M Rolland; D Bataille
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-01       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.